Li et al. demonstrated that hepatic CES2 plays an important role in controlling hepatic triglyceride homeostasis by regulating lipolysis, fatty acid oxidation (FAO), ER stress, and lipogenesis to alleviate liver steatosis and in improving glucose tolerance and energy expenditure. The gene discussed is CES2; the disease is Hepatic steatosis.